Tag: Diabetes: Misc.
Ertugliflozin Noninferior for CV Outcomes in T2DM With ASCVD
Ertugliflozin is noninferior to placebo for the primary end point of major adverse cardiovascular events
T2DM Links to Risk for Dementia Differ by Type, Glycemic Control
Dose-response association shows higher risk for dementia with HbA1c >87 versus <52 mmol/mol
September 2020 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for September 2020. This roundup includes...
Oral Steroids May Raise Risks for Diabetes, HTN, VTE in Children
But absolute risks for these complications still low among children receiving glucocorticoids
Individuals With Diabetes Have Increased Risk for Falls
Risk for falls higher in adjusted analysis for individuals with type 1 and type 2 diabetes
High Coronary Artery Calcium + Diabetes Even Riskier for Women
In adults with diabetes, high CAC score predicts CVD, total mortality more strongly in women than in men
Cardiovascular Health Tied to Lower Risk for Eye Diseases
Findings particularly strong for lowering risk for diabetic retinopathy
August 2020 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for August 2020. This roundup includes...
Diabetes Cuts Life Expectancy in U.K. by 6 Million Life Years
Findings based on a population-level model of U.K. residents with type 1 or type 2 diabetes
Shared Decision Making Improves Youth Continuous Glucose Monitor Use
Findings for study involving youth with diabetes, with follow-up two months after initiation
